WATERTOWN, Mass.--(BUSINESS WIRE)--Feb. 23, 2006--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the Wedbush Morgan Annual Small Cap Conference to be held at Le Parker Meridien Hotel in New York, NY March 1-2, 2006. Dr. Samuel Ackerman, Panacos' President and CEO, will give a corporate overview at 11:30 a.m. EST on Thursday, March 2.
